Sclerosis News and Research

RSS

Noninvasive gamma therapy may hold promise for treating chemo brain

Patients undergoing chemotherapy often experience cognitive effects such as memory impairment and difficulty concentrating -; a condition commonly known as "chemo brain."

6 Mar 2024

Study reveals safety of MS drugs during breastfeeding in child's early years of life

Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024.

4 Mar 2024

AI-powered transfer learning approach predicts gene perturbations that transform cell behavior

Technological advances in gene sequencing and computing have led to an explosion in the availability of bioinformatic data and processing power, respectively, creating a ripe nexus for artificial intelligence (AI) to design strategies for controlling cell behavior.

4 Mar 2024

People with sleep apnea more likely to have memory or thinking problems

People who experience sleep apnea may be more likely to also have memory or thinking problems, according to a preliminary study released today, March 3, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.

4 Mar 2024

Tandem cycling boosts well-being for Parkinson's patients and care partners

Pedaling on a stationary bicycle built for two may improve the health and well-being for both people with Parkinson's disease and their care partners, according to a small, preliminary study released today, February 29, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.

29 Feb 2024

Consistent Evidence Links Ultra-Processed Food To Over 30 Damaging Health Outcomes

Consistent evidence shows that higher exposure to ultra-processed foods is associated with an increased risk of 32 damaging health outcomes including cancer, major heart and lung conditions, mental health disorders, and early death.

29 Feb 2024

Study explores lifestyle factors linked to frequent headaches in youth

For children and teens, irregular meals such as skipped breakfasts are linked to an increased risk of frequent headaches, according to a new study published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that for those ages 12 to 17, substance use and exposure, specifically electronic cigarettes (e-cigarettes), were associated with frequent headaches.

29 Feb 2024

Social factors may be linked to access to stroke treatment

For people with stroke, social factors such as education, neighborhood and employment, may be linked to whether they receive treatment with clot-busting drugs according to a preliminary study released today, February 28, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.

28 Feb 2024

Seizure assistance dogs offer hope for people with drug-resistant epilepsy

For people with drug-resistant epilepsy, having a dog companion trained in detecting seizures and other epilepsy-related tasks may reduce the amount of seizures they have, according to new research published in the February 28, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Feb 2024

Genetic risk tool could aid early diagnosis and treatment of multiple sclerosis patients

Young people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start effective treatments.

28 Feb 2024

Pesticide use in farming linked to Parkinson's disease in the Rocky Mountain and Great Plains

Pesticides and herbicides used in farming have been linked to Parkinson's disease in the Rocky Mountain and Great Plains region of the country, according to a preliminary study released today, February 27, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.

27 Feb 2024

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Amyotrophic Lateral Sclerosis (ALS) is a fatal type of motor neuron disease characterized by progressive degeneration of nerve cells in the spinal cord and brain, resulting in muscle weakness and paralysis that can include the inability to walk and speak, or even swallow and breathe.

27 Feb 2024

Females' immune system edges out males but at a cost of higher autoimmune risk

A review article highlights how two X chromosomes in females influence immune system composition and function, leading to faster infection clearance and stronger vaccination responses but also a higher risk of autoimmune diseases.

22 Feb 2024

Major discovery improves the understanding of brain fog associated with Long COVID

Today, a team of scientists from Trinity College Dublin and investigators from FutureNeuro announced a major discovery that has profound importance for our understanding of brain fog and cognitive decline seen in some patients with Long COVID.

22 Feb 2024

Neural cell culture model sheds light on the intricate mechanisms underlying neurodegeneration

Scientists at the University of Zurich have developed an innovative neural cell culture model, shedding light on the intricate mechanisms underlying neurodegeneration.

22 Feb 2024

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

21 Feb 2024

Targeting the Hippo signaling pathway to treat systemic sclerosis

Systemic sclerosis causes the skin to tighten and harden resulting in a potentially fatal autoimmune condition that is associated with lung fibrosis and kidney disease.

21 Feb 2024

Study links air pollution with increased Alzheimer's markers

People with higher exposure to traffic-related air pollution were more likely to have high amounts of amyloid plaques in their brains associated with Alzheimer's disease after death, according to a study published in the February 21, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

21 Feb 2024

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a previously unknown mechanism behind this: other immune cells, the B cells, contribute to the "training" of the T cells in the thymus gland.

21 Feb 2024

IκBζ protein holds potential for treating autoimmune conditions

Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies.

21 Feb 2024

Sclerosis News and Research

Noninvasive gamma therapy may hold promise for treating chemo brain

Study reveals safety of MS drugs during breastfeeding in child's early years of life

AI-powered transfer learning approach predicts gene perturbations that transform cell behavior

People with sleep apnea more likely to have memory or thinking problems

Tandem cycling boosts well-being for Parkinson's patients and care partners

Consistent Evidence Links Ultra-Processed Food To Over 30 Damaging Health Outcomes

Study explores lifestyle factors linked to frequent headaches in youth

Social factors may be linked to access to stroke treatment

Seizure assistance dogs offer hope for people with drug-resistant epilepsy

Genetic risk tool could aid early diagnosis and treatment of multiple sclerosis patients

Pesticide use in farming linked to Parkinson's disease in the Rocky Mountain and Great Plains

FB1006: AI-discovered drug advances to clinical trials for ALS treatment

Females' immune system edges out males but at a cost of higher autoimmune risk

Major discovery improves the understanding of brain fog associated with Long COVID

Neural cell culture model sheds light on the intricate mechanisms underlying neurodegeneration

COVID-19's neurological effects linked to immune response, not direct viral attack

Targeting the Hippo signaling pathway to treat systemic sclerosis

Study links air pollution with increased Alzheimer's markers

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

IκBζ protein holds potential for treating autoimmune conditions

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News